News

Jessica Tyler, epigenetics, genetics, chromatin, cancer

2017 Nov 20

Jessica Tyler, Ph.D., Elected Fellow of AAAS

Dr. Jessica Tyler , who was recruited to Weill Cornell Medicine as a professor of pathology and laboratory medicine, has been elected a fellow of the American Association for the Advancement of Science (AAAS). Dr. Tyler was... Read more

2017 Nov 20

Mark M. Souweidane, M.D., Named to NCI’s Brain Malignancies Steering Committee

Mark Souweidane, M.D., has been selected by the National Cancer Institute (NCI) to serve as a member of its Brain Malignancies Steering Committee (BMSC). The committee is charged with reviewing and prioritizing Phase 2 and... Read more

2017 Nov 17

Todd Evans, Ph.D., Talks Cancer Organoids with the Daily Beast

Would you trust a 3D-printed mini organ to test your drugs? The Daily Beast's article on the matter features the perspective of Todd Evans, Ph.D., Associate Dean for Research. Read more

2017 Oct 27

L.A. Times Op-Ed Features MCC Director Lewis Cantley, Ph.D.

Science journalist Sam Apple interviewed Dr. Lewis Cantley for his opinion piece in the Los Angeles Times on the connection between sugar and cancer. Read more

2017 Oct 12

Ana Gomes, Ph.D., Selected as a 2017 STAT Wunderkind

As you get older, your risk of developing cancer increases. That might seem obvious, but Ana Gomes, Ph.D., wants to know why. She’s studying a chemical, found more prominently in older people than young, and how it may be... Read more

2017 Oct 06

Neuro-Oncologist Dr. Howard Fine Wins NIH Director’s Pioneer Award

Internationally renowned neuro-oncologist Dr. Howard A. Fine of Weill Cornell Medicine and NewYork-Presbyterian will receive a five-year, $6 million National Institutes of Health Director’s Pioneer Award for brain cancer... Read more

2017 Oct 05

MCC Researchers Receive Prostate Cancer Foundation 2017 Challenge Awards

Two of the 2017 Prostate Cancer Foundation (PCF) Challenge Awards were awarded to teams including Meyer Cancer Center investigators. Optimization of Prostate-Specific Membrane Antigen-Targeted Radiation ($1 million): Scott... Read more

2017 Oct 02

American Society of Hematology Bridge Grant Awarded to Selina Chen-Kiang, Ph.D.,

American Society of Hematology (ASH) announced the names of five investigators whose research has been awarded $150,000 through the ASH Bridge Grant Program. Meyer Cancer Center member Selina Chen-Kiang, Ph.D. was one of the... Read more

2017 Sep 27

The Differences Between Right- and Left-Sided Tumors in Colon Cancer

Video of The Differences Between Right- and Left-Sided Tumors in Colon Cancer Manish A. Shah, M.D., discusses the differences between right- and left-sided colon cancer. Read more

2017 Sep 21

How A Liquid Biopsy Changes Cancer Treatment

David Nanus, M.D., and Scott Tagawa, M.D., M.S., speak to Fox 5 News about liquid biopsies in cancer treatment. Read more

2017 Sep 21

Metastatic Breast Cancer Affects Bone Mineral Before Spreading

This article by Tom Fleischman first appeared in the Cornell Chronicle . When breast cancer metastasizes, or spreads, one of its most likely destinations is bone. In fact, four in five metastatic breast cancer patients will... Read more

2017 Sep 19

Phase II Study of Additional Treatment in Patients With Non-Hodgkin Lymphoma Shows No Significant Benefit

A phase II trial reported in the Journal of Clinical Oncolo gy by John P. Leonard, M.D., and collaborators showed no significant progression-free survival benefit of adding bortezomib to R-CHOP. Read more

2017 Sep 18

Epigenetic Code Plays a Role in Acute Myeloid Leukemia

This article by Bridget Kuehn first appeared in the Cornell Chronicle . Errors in the regulation of gene expression may contribute to the development of a common form of blood cancer and point to potential treatment... Read more

2017 Sep 15

Olivier Elemento, PhD, Appointed Director of the Englander Institute for Precision Medicine

Dr. Olivier Elemento , a renowned computational biologist and leader in the field of computational genomics and biomedicine, has been named director of the Caryl and Israel Englander Institute for Precision Medicine at Weill... Read more

2017 Sep 15

Double Targeting Ligands to Identify and Treat Prostate Cancer

John Babich, PhD, and collaborators have demonstrated a new way to identify and localize prostate cancer tumors while protecting healthy tissue and reducing side effects. Read the featured basic article of the September... Read more

prostate cancer neuroendocrine spore rubin beltran NEPC

2017 Sep 07

Meyer Cancer Center Investigators Awarded $11.3 Million Prestigious Grant for Prostate Cancer Research

The Weill Cornell Medicine Specialized Programs of Research Excellence (SPORE) in Prostate Cancer, led by Mark Rubin, M.D., has been funded by the National Cancer Institute (NCI). Read more

2017 Aug 31

The most important lesson I learned from a patient: Optimism Leads to Achievement

Brendon Stiles, M.D., reflects on his experience with an inspiring young patient. Read more

2017 Aug 30

Impact of the FDA Approval of CTL019 in ALL

Gail J. Roboz, M.D., discusses the impact of the FDA approval of tisagenlecleucel (CTL019; Kymriah) in select pediatric and young adult patients with a form of acute lymphoblastic leukemia (ALL). Read more

2017 Aug 30

Drug may curb female infertility from cancer treatments

An existing drug may one day protect premenopausal women from life-altering infertility that commonly follows cancer treatments, according to a study by Ithaca member John Schimenti, Ph.D. Read more

2017 Aug 29

The next steps for biopsies in prostate cancer

Jim Hu, M.D., MPH, discusses the next steps of biopsies for patients with prostate cancer. Read more

Global menu

You are here